1. Institute of Human Genetics, University Hospital Schleswig-Holstein Campus Kiel/Christian-Albrechts University Kiel, Kiel, Germany;
2. Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany;
3. Illumina, San Diego, CA;
4. Institute of Functional Genomics, University of Regensburg, Regensburg, Germany;
5. Cancer Epigenetics Laboratory, Spanish National Cancer Centre (CNIO), Madrid, Spain;
6. Foundation for Applied Medical Research, Division of Cancer and Area of Cell Therapy and Hematology Service, Clínica Universitaria, Universidad de Navarra, Pamplona, Spain;
7. Institute of Pathology, University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany;
8. Institute of Pathology, Kantonsspital St Gallen, St Gallen, Switzerland;
9. DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany;
10. Institute of Pathology, University Hospital of Frankfurt, Frankfurt, Germany;
11. Institute of Pathology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Berlin, Germany;
12. Institute of Hematopathology, University Hospital Schleswig-Holstein Campus Kiel/Christian-Albrechts University Kiel, Kiel, Germany;
13. Genomics and Proteomics Core Facility, German Cancer Research Center, Heidelberg, Germany;
14. Institute for Cell Biology (Tumor Research), University of Duisburg-Essen, Essen, Germany;
15. Institute of Pathology, University Hospital of Ulm, Ulm, Germany;
16. Institute of Pathology, University of Würzburg, Würzburg, Germany;
17. Second Medical Department, University Hospital Schleswig-Holstein Campus Kiel/Christian-Albrechts University Kiel, Kiel, Germany;
18. Cytogenetic and Molecular Diagnostics, Internal Medicine III, University Hospital of Ulm, Ulm, Germany;
19. Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland; and
20. Department of Hematology and Oncology, Georg-August University of Göttingen, Göttingen, Germany